|
Nikolay Savchuk, Chairman ChemDiv Research Institute speaks at BIO session Emerging Markets Become Strategic Markets: Biotechs Looking Internationally for R&D, Manufacturing, and Market Opportunities on Wednesday, June 20th at 10am -11:30 am, Room 256
|
|
San Diego Convention Center
Meet ChemDiv representatives at our booth # 651
Contact: Roulsan Michtechenko, BD Director
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
For more information about event, please visit SLAS 2012 |
|
San Diego, Biocom
Out-sourcing of drug discovery and development processes by integrated and specialty pharmaceutical companies is now well-established. Large Pharma can effectively resource and deploy R&D managers to operate development programs on a global scale. Outsourcing is also growing among startup and established biotechs in response to the challenges of scarce capital for early stage discovery and development and the need to advance and validate ideas and hypotheses in more rapid and cost-effective ways. However, for many small biotech companies, managing geographically dispersed R&D efforts can be challenging. These trends raise critical issues for early stage biotech entrepreneurs; questions such as what to focus on, what strategies to pursue for seed funding; and require decisions about what to manage, what to build, and what to outsource. In response to these pressures, contract research organizations have sprung up in the San Diego and southern California region. Their regional presence makes outsourcing of R&D by small and startup biotechs feasible.
|
|
San Francisco, CA
Attendees:
Slava Katin, Business Development Executive:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Rouslan Michtchenko, Director Business Development:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
BSG House, London, UK
Podium Presentation by Dr. Michael G. Palfreyman Head, Translational R&D, ChemDiv / Executive Program Director, Senior Scientific Advisor, EnVivo Pharmaceuticals
March 16 at 2:10PM
Use of biomarkers for demonstrating CNS effects of drugs early in clinical development
|
|
Ocean Place Resort - Long Branch, NJ
Speaker:
Dr. Michael G. Palfreyman Head, Translational R&D, ChemDiv / Executive Program Director, Senior Scientific Advisor, EnVivo Pharmaceuticals
|
Boston, MA
Attendees:
Slava Katin, Business Development Executive:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Rouslan Michtchenko, Director Business Development:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
|
|
|
|
Events
